Jow W W, Zeid M Y, Cowan D, Malin B, Deberry J L
Department of Urology, State University of New York, Buffalo.
J Surg Oncol. 1991 Jan;46(1):53-9. doi: 10.1002/jso.2930460113.
We report a retrospective study on the clinicopathologic features and flow cytometric DNA analysis of ten renal oncocytomas compared with a control group of ten randomly selected renal cell carcinomas. Among the oncocytoma patients, no recurrences or metastases were noted over an average follow-up of 6.7 years (range = 6 months to 16 years). Reproducible, high-quality DNA histograms were obtained on the paraffin-embedded specimens by using our modified flow cytometric procedure. One aneuploid (10%) and two hyperdiploid tumors (20%) were found in the oncocytoma group. There was no correlation between these abnormal DNA histographic patterns and survival or tumor stages. On the contrary, a good correlation was found between tumor grades and DNA ploidy in the controls. We conclude that renal oncocytoma is a clinically benign tumor, yet it may exhibit varying degrees of flow cytometric DNA abnormalities, which have no predictive value on survival and probably reflect the characteristics of oncocytes rather than its malignant potential.
我们报告了一项回顾性研究,该研究对10例肾嗜酸细胞瘤的临床病理特征及流式细胞术DNA分析结果进行了研究,并与随机选取的10例肾细胞癌组成的对照组进行了比较。在嗜酸细胞瘤患者中,平均随访6.7年(范围为6个月至16年)未发现复发或转移情况。通过我们改良的流式细胞术程序,在石蜡包埋标本上获得了可重复的高质量DNA直方图。在嗜酸细胞瘤组中发现1例非整倍体肿瘤(10%)和2例超二倍体肿瘤(20%)。这些异常的DNA直方图模式与生存情况或肿瘤分期之间无相关性。相反,在对照组中发现肿瘤分级与DNA倍性之间存在良好的相关性。我们得出结论,肾嗜酸细胞瘤是一种临床良性肿瘤,但它可能表现出不同程度的流式细胞术DNA异常,这些异常对生存无预测价值,可能反映了嗜酸细胞的特征而非其恶性潜能。